GI Medical Oncologist At Dana-Farber. Pancreatic cancer researcher, runner, cyclist, med educator. Tweets are not medical advice. Please refrain from lawsuits.
@TenMyou5@PokemonGOHubNet Where did it say guaranteed? I thought it was 1 in 20 odds. Re: ratta, about a 2% chance of not seeing one out of 2,000 caught. That's pretty lousy luck, but not outlandish.
@US_FDA@AACR An important topic being discussed today. It is time to standardize DPYD testing prior to first exposure to fluoropyrimidines. Each story of a DPD-related death is heartbreaking as it could have been prevented with an inexpensive test. #AACRSciencePolicy
@decoding_engg The 52nd Mersenne prime should be announced within days pending final proof per https://t.co/79XuqgUzUd. The first new Mersenne prime in 6 years.
In oncology, we spend a lot of money/effort trying to find new drugs. The best drug in GI cancers continues to be 5-Fluorouracil (5-FU) - a drug which costs <$1/dose. We could likely be using this drug far better. Here's a first step: https://t.co/nhEQCcEI94
The man behind me on my flight identified Robin Williams as his favorite current comedian, and then indicated that he was torn, as he felt Gallagher is a genius (present tense).
A year ago, I sent Andy Aguirre and Ryan Corcoran an email asking if there was any way I could target my patient's NRAS G12C mutated colon cancer. Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers https://t.co/oPA6oUrLbo
Friends with a passion for medical education - there is a really exciting opportunity at Dana Farber to transform education. DFCI is creating an Institute Level Senior VP faculty position for an MD with a track record and passion for education. https://t.co/UcK8UAmPkW